Steeve Néron
Corporate Officer/Principal at TETRA BIO-PHARMA INC.
Steeve Néron active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 16/09/2020 | - |
| Chief Operating Officer | 31/10/2019 | - | |
| Sales & Marketing | 12/11/2018 | 31/10/2019 | |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Director/Board Member | - | - |
Career history of Steeve Néron
Former positions of Steeve Néron
| Companies | Position | Start | End |
|---|---|---|---|
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 30/04/2013 | 31/01/2018 |
Training of Steeve Néron
| Université du Québec à Chicoutimi | Undergraduate Degree |
Statistics
International
| Canada | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Stock Market
- Insiders
- Steeve Néron
- Experience
